A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
Clinical trial NCT03361228 · TERMINATED
Trial details
- NCT number
- NCT03361228
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-03-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.